Stay updated on Ixazomib Citrate for Relapsed Myeloma Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.

Latest updates to the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page
- CheckyesterdayChange DetectedNo significant changes detected between the two screenshots. The page content and structure appear unchanged, continuing to present the Study Details for NCT01415882.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedCore content updated to inform users about funding-related operating status and current NIH Clinical Center openness; version updated from v3.1.0 to v3.2.0.SummaryDifference2%

- Check30 days agoChange Detected- Added revision tag v3.1.0 and removed the Plasma cell myeloma resource from the Genetic and Rare Diseases Information Center list. Overall: minor content update with a resource removal.SummaryDifference0.3%

- Check44 days agoChange DetectedAdds an estimated Last Update Posted and Revision: v3.0.2, replacing Last Update Posted and Revision: v3.0.1; also removes the Back to Top link.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page has been updated to reflect the completion status of a study and the revision number has been incremented, indicating a new version of the document. Additionally, the identifier for the Mayo Clinic has been modified to remove the specific location reference.SummaryDifference1%

- Check59 days agoChange DetectedThe web page has added significant information regarding a facility and its location, as well as various medical compounds and treatments related to plasma cell myeloma, while removing several related topics and terms.SummaryDifference4%

Stay in the know with updates to Ixazomib Citrate for Relapsed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.